Lianda Ch Luijpers

Lianda Ch Luijpers

Auto-generated profile, based on publicly available information

Lianda Ch Luijpers

Department of Medical BioSciences (Route 928), Radboud University Medical Center, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2018 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
HJHussein Jamaladin
Hussein Jamaladin
TBTom H van de Belt
Tom H van de Belt
LLLianda Ch Luijpers
Lianda Ch Luijpers
FGFalco R de Graaff
Falco R de Graaff
SBSebastian JH Bredie
Sebastian JH Bredie
MGMarleen van Gelder
Marleen van Gelder
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Using a mobile application for self-management could make it easier for patients to get insight into their blood pressure patterns. However, little is known about the availability, quality, and features of mobile apps targeting blood pressure. Objective: To determine the availability, functionality, and quality of mobile applications that could be used for blood pressure monitoring purposes. Methods: The systematic literature review framework was applied to the search, screening, and assessment of applications. We included all English and Dutch mobile applications targeting blood pressure that were available in the official app stores of Android and iOS. Two independent assessors determined eligibility and quality of the applications using the five point Mobile App Rating Scale. Quality scores of the applications with and without 17 a priori selected characteristics were compared using independent sample t-tests. Results: A total of 184 applications (104 Android, 80 iOS) met the inclusion criteria. The mean overall Mobile App Rating Scale score was 2.63 (95%CI 2.55, 2.71) for Android and 2.64 (95%CI 2.56, 2.71) for iOS. The applications ‘Bloeddruk’ (4.1) and ‘AMICOMED BP’ (3.6) had the highest quality scores on the Android and iOS platforms, respectively. Of the application characteristics recorded, only pricing, in-app advertisements, and local data storage were not associated with the quality scores. In only 3.8% of the apps, involvement of medical experts in its development was mentioned, whereas none of the apps was formally evaluated and published in peer-reviewed journals. Conclusions: This study provides an overview of the best applications currently available in the application stores and important key features for self-management that can be used by healthcare providers and patients with hypertension to identify a suitable application targeting blood pressure monitoring. However, the majority of the applications targeting blood pressure monitoring were of poor quality. Therefore, it is important to involve medical experts in the developmental stage of health-related mobile applications to improve the quality of these applications.

7 September 2024 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
CLCornelia Lianda H. Luijpers
Cornelia Lianda H. Luijpers
MNMalou A. H. Nuijten
Malou A. H. Nuijten
EGEvi J. Groenhuijzen
Evi J. Groenhuijzen
LHLilian L. van Hogezand
Lilian L. van Hogezand
VMValerie M. Monpellier
Valerie M. Monpellier
MHMaria T.E. Hopman
Maria T.E. Hopman
Purpose: Disproportional fat-free mass loss often occurs post-bariatric surgery, partly due to insufficient protein intake during the post-surgery recovery phase. We compared five protein-enhancing strategies (PES) on patient tolerability, satisfaction and protein intake. Materials and Methods: Ninety-four participants, scheduled for bariatric surgery, were enrolled and allocated to either of the following: (1) whey powder, (2) hydrolysed collagen powder, (3) plant-based powder, (4) protein-rich products, (5) protein gel, or control. PES groups were instructed to add 30 g of powder or 2 gels or protein products to their diet. Patient satisfaction and tolerability were evaluated with questionnaires. Dietary intake was assessed prior to and during PES use. Results: Seven patients dropped out (i.e. loss of contact, personal reasons or post-surgery complications) yielding an analytical cohort of 87 participants. The majority of patients (61%) did not experience dietary complaints from PES and could use PES ≥ 5 days of the week. PES non-usage was mainly related to taste dislike (58%). Hydrolysed collagen scored highest on tolerability and satisfaction: 86% of the participants could use HC ≥ 5 days and 71% were satisfied with the product. PES increased protein intake from 54.7 ± 21.5 g/day to 64.7 ± 23.4 g/day during the intervention (p = 0.002), which differed from the control group (+ 10.1 ± 24.5 g/day vs. − 6.3 ± 23.8 g/day for controls, p = 0.019). Whey showed the highest increase, namely + 18.3 ± 16.3 g/day (p = 0.009). Conclusion: PES were tolerated by the majority of participants, and an improved protein intake with PES use was seen. However, the taste of the products could be improved to further enhance satisfaction and tolerability. Graphical

19 January 2018 in JMIR Preprints
Verified
Preprint
Open access
HJHussein Jamaladin
Hussein Jamaladin
TBTom H van de Belt
Tom H van de Belt
LLLianda Ch Luijpers
Lianda Ch Luijpers
FGFalco R de Graaff
Falco R de Graaff
SBSebastian JH Bredie
Sebastian JH Bredie
MGMarleen van Gelder
Marleen van Gelder
BACKGROUND Using a mobile app for self-management could make it easier for patients to get insight into their blood pressure patterns. However, little is known about the availability, quality, and features of mobile apps targeting blood pressure. OBJECTIVE The goal of the research was to determine the availability, functionality, and quality of mobile apps that could be used for blood pressure monitoring purposes. METHODS A systematic app search was performed based on the standards for systematic reviews. We searched the Dutch official app stores for Android and iOS platforms using predefined keywords and included all English and Dutch mobile apps targeting blood pressure. Two independent assessors determined eligibility and quality of the apps using the 5-point Mobile App Rating Scale (MARS). Quality scores of the apps with and without 17 a priori selected characteristics were compared using independent sample t tests. RESULTS A total of 184 apps (104 Android, 80 iOS) met the inclusion criteria. The mean overall MARS score was 2.63 (95% CI 2.55-2.71) for Android and 2.64 (95% CI 2.56-2.71) for iOS. The apps Bloeddruk (4.1) and AMICOMED BP (3.6) had the highest quality scores on the Android and iOS platforms, respectively. Of the app characteristics recorded, only pricing, in-app advertisements, and local data storage were not associated with the quality scores. In only 3.8% (7/184) of the apps, involvement of medical experts in its development was mentioned, whereas none of the apps was formally evaluated with results published in a peer-reviewed journal. CONCLUSIONS This study provides an overview of the best apps currently available in the app stores and important key features for self-management that can be used by health care providers and patients with hypertension to identify a suitable app targeting blood pressure monitoring. However, the majority of the apps targeting blood pressure monitoring were of poor quality. Therefore, it is important to involve medical experts in the developmental stage of health-related mobile apps to improve the quality of these apps.

20 October 2025 in Obesity Facts
Verified
Journal Article
Open access
CLCornelia H. (Lianda) Luijpers
Cornelia H. (Lianda) Luijpers
MNMalou A.H. Nuijten
Malou A.H. Nuijten
VMValerie M. Monpellier
Valerie M. Monpellier
BRBente de Roos
Bente de Roos
JKJan H.M. Karregat
Jan H.M. Karregat
MHMaria T.E. Hopman
Maria T.E. Hopman
Introduction: Metabolic and bariatric surgery (MBS) leads to substantial muscle mass loss. Resistance training (RT) is an effective strategy to maintain muscle mass. This study aimed to gain insight into the motivators, barriers, and preferences that are correlated with RT uptake after MBS. Methods: A digital survey assessing RT was sent to patients who had MBS 1–18 months prior. Patient characteristics were extracted from electronic health records. Motivators, barriers, and preferences were assessed with a questionnaire and compared across three groups: patients currently engaged in RT (RT-group), previously engaged in RT (ex-RT), or never engaged in RT (non-RT). Results: Among 1,609 participants (77% female, 47 ± 11 years old, BMI 42 ± 5 kg/m2), 68% were classified as RT-group, 11% as ex-RT, and 21% as non-RT. The RT-group reported improving fitness (78% vs. 67%), mental health (65% vs. 43%), and overall health (63% vs. 41%) more often as motivators for RT than the ex-RT. RT barriers were comparable between ex-RT and non-RT, most frequently lack of motivation (37% vs. 40%), time (33% vs. 28%), enjoyment (29% vs. 29%), and physical complaints (39% vs. 37%). Ex-RT and non-RT reported a preferred exercise frequency of 2 sessions/week with 30 min/session, in their home setting with a training schedule and guidance from a professional. Conclusion: The majority of participants in our study engaged in RT. We identified improving overall fitness and limiting strength or muscle loss as motivators, lack of motivation, physical complaints, lack of time and enjoyment as barriers, and professional guidance and a training schedule for RT at home as facilitators, which were correlated to RT uptake after MBS.